Healogix

Back to About Healogix

Drug marketers face an unenviable challenge: spend hundreds of millions of dollars over several years before seeing if their investment was justified.

Into this environment, Healogix introduces RAMP^SM (Rapid Adoption & Market Potential) a new and powerful process to "build-in" commercial success at the level of the product's label (which in this highly-regulated environment constitutes the sole source of marketing messages the drug marketer can deploy) -- as early as possible, before investing heavily in clinical trials.

The Healogix process combines:

• Therapeutic area knowledge and clinical expertise
• Regulatory knowledge and promotional claim assessment expertise
• Identification of key "choice drivers":
  • from the patient's perspective, which treatment outcomes impact the patient's willingness to pay for and use a drug, compared to alternatives
  • from the prescriber's perspective, which clinical and practice-related outcomes impact the physician's willingness to prescribe a drug, compared to alternative regimens and to the formularies payers are promoting
  • from the payer's perspective, which clinical outcomes impact a payer's willingness to reimburse compared to current treatment/outcomes options
• Integration and quantification, through new analytical technologies, of the threshold values at which drivers can influence behavior changes
• Distillation into robust interactive models to enable scenario evaluation
• Consultation to turn the research-driven label definitions into action plans

Healogix' RAMP^SM process allows you to build-in commercial success before spending all the money developing the product and the claims. This approach is made possible by our proprietary technology, but the impetus is the simple recognition that the biggest approval of all that drug marketers need isn't the FDA, nor is it DDMAC -- it is the marketplace!